RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $405
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix maintains an Outperform rating on HCA Healthcare and raises the price target from $378 to $405.
August 23, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has increased the price target for HCA Healthcare from $378 to $405 while maintaining an Outperform rating, indicating positive expectations for the stock.
The increase in price target from $378 to $405 by RBC Capital suggests a positive outlook for HCA Healthcare. The maintained Outperform rating indicates that the analyst expects the stock to perform well relative to the market. This is likely to have a positive short-term impact on the stock price as investors may view this as a strong endorsement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100